Related Experiment Video
Updated: Jan 11, 2026

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
Published on: September 22, 2023
Immunotherapy in Allergic and Mixed Rhinitis
Tolly Epstein1, David I Bernstein1
1Division of Immunology, Allergy and Rheumatology, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Allergen immunotherapy, including subcutaneous (SCIT) and sublingual (SLIT) methods, effectively treats allergic rhinitis. SLIT offers a superior safety profile, making it a preferred option for managing allergy severity.
Area of Science:
- Allergy and Immunology
- Immunotherapy Research
- Respiratory Medicine
Background:
- Allergic rhinitis significantly impacts quality of life.
- Allergen immunotherapy is the sole disease-modifying treatment.
- Current options include Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT).
Purpose of the Study:
- To review the efficacy of individual allergens in immunotherapy.
- To compare the relative efficacy of SLIT and SCIT.
- To assess the safety profiles of SLIT and SCIT.
Main Methods:
- Literature review of existing studies.
- Analysis of clinical trial data.
- Comparative assessment of treatment outcomes and adverse events.
Main Results:
- Both SCIT and SLIT demonstrate significant efficacy in treating allergic rhinitis.
- SLIT is associated with a better safety profile and fewer systemic reactions.
- Evidence supports the effectiveness of specific allergens within immunotherapy protocols.
Conclusions:
- Allergen immunotherapy is a cornerstone treatment for allergic rhinitis.
- SLIT presents a favorable safety and efficacy balance.
- Further research can refine allergen selection and delivery methods for optimal patient outcomes.
Related Concept Videos
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Allergic Reactions
Tumor Immunotherapy
Allergic Drug Reactions

